MedTrace Logo

Promoting Successful Weight Loss in Primary Care in Louisiana

NCT02561221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 803

Last updated 2023-08-01

Study results available
· View outcomes & findings →

Summary

The primary aim of this trial is to develop and test the effectiveness of a 24 month, patient-centered, pragmatic and scalable obesity treatment program delivered within primary care, inclusive of an underserved population. Half of the clinics received a behavioral intervention delivered in a primary care setting and half of the clinics received usual care.

Conditions

Interventions

BEHAVIORAL

Lifestyle Counseling

Trained health coaches delivered the active intervention - a comprehensive, "high-intensity" program, as recommended first-line therapy by the 2013 American Heart Association/American College of Cardiology/The Obesity Society Guidelines.

Sponsors & Collaborators

  • Louisiana State University Health Sciences Center Shreveport

    collaborator OTHER

  • Tulane University

    collaborator OTHER

  • Ochsner Health System

    collaborator OTHER

  • Louisiana State University Health Sciences Center in New Orleans

    collaborator OTHER

  • Xavier University of Louisiana.

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Peter T Katzmarzyk, PhD · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-09-06
Completion
2019-09-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02561221 on ClinicalTrials.gov